La chaîne d'options affiche les données clés des options sur actions de iBio à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour iBio..

iBio (NASDAQ:IBIO) Stock, Chaîne d'Options

iBio

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

iBio Inc

News

Financing

Press Releases

iBio Raises $6.2 Million Through Warrant Inducement Transaction

Earnings

iBio Reports Fiscal Third Quarter 2025 Financial Results

Health Care

iBio's First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical Model

General

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment

iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

iBio Announces Proposed Public Offering

iBio Announces Pricing of $50 Million Public Offering

iBio Announces Closing of $50 Million Public Offering

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

IBIO

Ainos

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

Carisma Therapeutics, Inc. - Common Stock

CARISMA Therapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Curis

Edesa Biotech

Enlivex Therapeutics Ltd. - Ordinary Shares

Enlivex Therapeutics

Evaxion

FibroBiologics

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Geovax Labs

Longeveron

Lisata Therapeutics

MetaVia

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

Nanoviricides

NextCure

Passage Bio

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences

Q32 Bio

Rein Therapeutics

SAB Biotherapeutics

Synlogic

Tharimmune

Exicure

Chardan Capital

LUCID CAPITAL MARKETS

Brookline Capital

Cantor Fitzgerald

Comments

iBio

iBio (IBIO) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL